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From the
President

"If the human race wishes to have a prolonged
and indefinite period of material prosperity,
they have only got to behave in a peaceful and
helpful v1ay toward one another."
- Sir Winston Churchill

Colleagues,
Well, the first month of the new year is
here and gone. We've had the first
meeting of the Medical Executive
Committee of the Lehigh Valley
Hospital/Muhlenberg Hospital Center
combined medical staff. Drs. Linda Blose,
Hugo Twaddle, John Mannisi, and John
Lang attended the meeting as the elected
representatives from Muhlenberg Hospital
Center. I'll be trying to have a
presentation at the Medical Executive
Committee each month regarding some
issue Troika feels is relevant to the
combined medical staff.
At the January meeting, John Stavros
presented the results of a survey of 385
Lehigh and Northampton County patients
and 100 "community leaders" about their
perception of the Lehigh Valley Hospital.
The report of this survey was
predominantly positive. One of the
notable points of the survey was that the
hospital and its medical staff are not seen
as being as "compassionate and caring"
as some of the other hospitals in the area.
Troika feels that this result needs to be
addressed by the medical staff and that a
plan needs to be formulated to try to
(Continued on Page 2)
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improve this perception. We will be helping to develop a
program to address this issue. All of us on our daily clinical
rounds need to take time to answer our patients' questions,
make sure they understand their problems and our plans to
diagnose and treat them, and be sure that we are trying to make
their stay in the hospital as positive an experience as possible.
Bob, Ed, and I will try our best to maintain timely communication
with the medical staff. We will continue to use Medical Staff
Progress Notes as our primary vehicle for communication. We
are told that most physicians read the "Progress Notes" and will
continue to use this as the major method of communication for
large issues. Unfortunately, "Progress Notes" is only published
monthly. There may be issues which require more rapid means
of communication.
This leads me to the subject of email. I know that many of the
members of the medical staff do not use email, or do so only
infrequently. Email is a convenient vehicle for rapid communication. Physicians can assign someone on their staffs to
function as their "surrogate" to read and print out important
email messages. I would recommend that if you don't use the
email system regularly, you should assign a surrogate from
your office to read your email frequently and print out
important messages for you to read at your leisure. We will be
using email to keep members of the medical staff informed
about important and timely issues which need to be discussed
before the next issue of Medical Staff Progress Notes is
published. For those of you who do use email, Ed, Bob, and I
would be glad to receive your messages via that route.
In our professional clinical activities, I would also encourage all
of us to try to maintain personal communication between our
colleagues on the medical staff regarding our patients. As we
tried to encourage several years ago in the "Guidelines for
Consultations," the personal communication between
physicians is vitally important in insuring excellent patient care.
We can be much more efficient in caring for our patients if we
communicate with our colleagues personally. Recently the
practice of physicians writing the order, "Discharge patient if
O.K. with Dr. X" has created confusion and has resulted in
consternation between physicians, nurses, and patients. It
would be much better if Dr. X called Dr. Y personally to
discuss the possible discharge of a patient. I would
encourage this practice as we try to deal with other physician
colleagues and the nursing staff as the professionals we are.
Telephone calls to our physician colleagues may take a little
more time, but will result in better and more efficient patient
care. It will also help to nurture closer professional relationships between physicians. And, it's good for patient care!
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We will also be reinstituting the "Medical Staff/Administration
Exchange Sessions" on an "as needed" basis so that
members of the medical staff can provide input prior to
(
important decisions being made. Hopefully, these sessions
will provide an opportunity for interested members of the
medical staff to present their views to members of the hospital
administration.
Over the next several months, I'll be inviting members of the
medical staff to meet with me personally to discuss issues
which they feel are important to themselves, the medical staff
in general, and the hospital. I hope I'll be able to learn from
these sessions so that Troika will be better able to address
issues of importance to the medical staff.
Finally for this month, I'd like to begin to address the
organization of the Lehigh Valley Hospital patient medical
record (chart). I've been concerned for some time that the
present LVH patient chart does not appear to be "user
friendly." It seems to me that there might be a better way for
the medical record to be organized so that we as physicians
would find the chart more useful and more efficient to use in
our daily care of patients. Ed Mullin, as former chair of the
Medical Records Committee, has also expressed this
sentiment. There is no "correct" or required way for the patient
chart to be organized. JCAHO does not specify how patient (
charts need to be ordered. Before we begin any attempt to .
change the organization of the patient medical record, I'd like
to have input from the medical staff as to whether you feel the
present patient chart is organized in a way which is most
useful to you on your daily rounds. If you agree {or disagree)
with me that the patient charts might be better organized,
please communicate your ideas and suggestions to me via
email, letter, or hallway contact. I assure you that no change
in the present medical record will occur unless there is a
consensus from the medical staff that there should be a
change.
I hope you all have a good, safe, and healthy month of
February. As we move ahead, let's try to consider Sir Winston
Churchill's quote and apply it to our professional relationships.
Remember, I'll be in the medical staff office on the second
floor across from the OR lounge at Cedar Crest & 1-78 every
Monday afternoon from 1 to 3:30 p.m., to meet with members
of the medical staff who are interested in scheduling an
appointment. Please call Beth Martin at 402-8980 to schedule
an appointment.

&rJJ

David M. Caccese
Medical Staff President

(
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Flu Update

Physiatry Consults

Influenza A has arrived! The following are a few notes to
assist in the management of suspected and confirmed
Influenza A patients in the hospital environment.

Some confusion was recently identified regarding the
ordering of Physical Medicine and Rehabilitation or
Physiatry consults vs. evaluation of patients for transfer to
Good Shepherd (GSRH Eval), particularly in the
Transitional Skilled Unit (TSU).

(

=> Cases admitted to the hospital with influenza high on
the differential list of diagnoses should be placed on
Droplet Isolation (which requires a private room)
immediately upon admission.
=> Cases can be confirmed by viral culture or made
clinically (high fever, severe myalgia, multiple cases,
short [three day] incubation). Viral culture kits are
available through the Outpatient Department,
Emergency Departments, or by calling 402-8170.
=> Rimantadine (Fiumadine) at 100 mg twice a day is
helpful for prevention or therapy for Influenza Type A.
Modify dosage to once a day for renal insufficiency
and/or >65 years.

(

=> Infection Control will notify the physicians of roommates
of patients identified with influenza to alert them to the
potential exposure. In these instances, it is
recommended the physician inquire about vaccination
history and watch for flu-like symptoms in unvaccinated
patients.
=> Patients vaccinated for influenza post exposure should
be continued on Rimantadine for 14 days allowing for
the vaccine to take effect.

When the attending physician orders an evaluation by the
Good Shepherd nurse liaison for possible admission to
Good Shepherd, it should be worded "Good Shepherd
Nurse Liaison Eval" (776-3293).
When the ordering physician orders a consultation with a
physiatrist, the order should be worded "PMR (or physiatry)
evaluation-- Dr.
for Reason." Examples of
reasons could include, but are not limited to "evaluate rehab
needs and recommend appropriate care," "evaluate and
recommend appropriate level of rehab care," or "evaluate
falls/gait abnormalities and recommend treatment."
Identifying the appropriate rehabilitation destination based
on the many options available to your patients (TSU,
Muhlenberg Rehabilitation Center, Affinity, other outpatient
sites, comprehensive inpatient rehabilitation, and
homecare) has become complicated and confusing.
Physiatrists are available to assist you in educating your
patients and their families regarding which of the many
settings are appropriate based on their rehab needs.
If you have any questions regarding this issue, please
contact Jane Dorval, MD, Chief, Division of Physical
Medicine & Rehabilitation, via e-mail or at 776-3340.

=:> Although the optimal time for influenza vaccination is

October through mid-November, healthcare providers
should continue to offer influenza vaccine up to and
even after influenza activity has been detected in the
community, particularly to those persons at high risk for
influenza-related complications.
Witnessing the admissions related to complications from
influenza serves as a constant reminder of the need for high
risk individuals to be placed on a yearly vaccination
schedule for influenza by their health care provider. It also
reminds us all of our responsibility as healthcare providers
to be vaccinated as well to reduce the risk of transmission
to our patients.
If you have any questions, please contact the Infection
Control Department at 402-0680.

Edgardo S.G. Cruz, MD Memorial Fund
A memorial fund has been established in honor of our fnend
and colleague, Edgardo S G. Cruz, fvlD The memorial fund
will be divided up among Dr Cruz's favorite charitable
organizations. Donations should be made payable to
Susan Cruz. c/o The fvlemonal Fund of
Edgardo S G. Cruz, rvlD
American Bank
4029 W. Tilghman Street
Allentown. PA 18104
The Cruz family deeply appreciates the expressions of
sympathy and support they have rece1ved throughout this very
difficult time.
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Transfusion Medicine: HCV (Hepatitis C
Lookback Notifications)
In an attempt to identify persons at high risk for developing
chronic liver disease, the Surgeon General, Centers for
Disease Control, and the American Liver Foundation are
recommending that patients who received transfusions prior
to 1992 be tested for the presence of HCV antibodies.
The first generation test for HCV was introduced in 1990,
and most blood centers, including Miller Memorial Blood
Center, had started testing donor blood immediately. A
second generation test was introduced in 1992. The
second generation test is at least 25% more sensitive than
the first. It also eliminated a large number of false positive
results seen with the first generation.
In addition to this general advisory, a targeted lookback
process has also been mandated by the Food and Drug
Administration (FDA). In this targeted lookback, if a current
blood donor tests positive for HCV, previous recipients of
blood from this particular donor are identified and tested for
HCV. All testing is done confidentially at the blood center
free of charge. Informational letters to help with this testing
and counseling are sent to the current or known health care
provider of the patient. For patients with no known
attending physician, a certified letter will be sent to the
patient at their last known address. FDA mandates that
transfusion services make at least three good faith attempts
to notify the previous recipients of blood from donors who
are now testing positive.
For patients who are not part of the targeted lookback,
testing should go through the normal laboratory channels as
a part of a hepatitis profile or just HCV testing. The usual
lab charges will apply.
Lehigh Valley Hospital and Health Network is expecting a
large number (300-500) of these lookback letters from the
blood center. Our process will identify the recipients and
notify the current attending physician or the physician of
record first verbally and then be followed by a notification
package containing all the materials required to complete
this process. This process must be completed within a
defined time period.
The current risk for HCV is estimated to be approximately
1:100,000.
If you have any questions; please contact Bala B. Carver,
MD, Medical Director, Transfusion Medicine, at 402-8142.
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Breast Health Services in Top 5%
(

Recently, Breast Health Services passed their FDA
inspection for mammography accreditation with no
contingencies. This places Lehigh Valley Hospital and
Health Network's Breast Health Services among the top 5%
in the nation who enjoy such success.
The Mammography Quality Standards Act requires that
mammography facilities undergo inspection by the
Department of Health and Human Services (Food and Drug
Administration) on an annual basis. The focus of the
inspection included: equipment performance, technologist
quality control, medical physicist survey, personnel
qualifications, medical reports and outcome audits. There
are defined standards in each of these areas which are
thoroughly scrutinized by the inspectors during their annual
visits. Additionally, patient satisfaction surveys performed
nationwide by Press Ganey have placed Breast Health
Services in the top 99.6%.

Such results can only be achieved by a caring, successful
team. The program is fortunate to have the strong
leadership of Gregory R. Harper, MD, PhD, and Elisabeth
Ladd, RN, MSN. The recent addition of John G. Pearce, (
MD, as Director of Breast Imaging and Associate Director 01
Breast Health Services has allowed for rapid transition
toward the ultimate goal of a comprehensive breast center.
Prior to his arrival here, Dr. Pearce was the Director,
Outpatient Department- Radiological Services at LAC/USC
Medical Center, Los Angeles, Calif. He brings strong
leadership to the mammography program and shares a
vision in keeping with Lehigh Valley Hospital's strategic plan
for growth. Dr. Pearce is an internationally known
mammographer and educator, and his arrival has quickly
promoted Breast Health Services at Lehigh Valley Hospital
and Health Network into a leading role for modem breast
health care in the community.
The staff of Breast Health Services has increased
community outreach by speaking to community groups
including Allentown City Hall employees, Regional
Technology in the Poconos, Encore Breast Cancer
Survivors' Public Education Program of the YWCA, and the
Nazareth Senior Center. Community involvement is critical
to promote optimal breast health for the women of the
Lehigh Valley.

(
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Ordering Mammography
(

(o order and bill for mammography, the facility performing the
study must provide information related to the type of study
being performed and the diagnosis or chief complaint
supporting the study. A screening mammogram is ordered for
a patient for whom there is no suspicion of an underlying
problem. Its purpose is to screen for an occult malignancy.
Screening mammography is covered by Medicare and most
insurers annually after age 40, though coverage may be
subject to a deductible. The chief complaint for a screening
study is "screening mammogram." NoV code or additional
high risk information is to be submitted by current Medicare
guidelines.

Diagnostic mammography is ordered for those patients
demonstrating a current breast symptom with an appropriate
diagnosis code. The only V code which is acceptable when a
diagnostic mammography is performed is V10.3, previous
history of breast cancer. Please note that not all insurers
consider fibrocystic disease (611.1) to be justification for a
diagnostic mammography; in such cases the claim may be
rejected by the patient's insurance. Similarly, screening
studies performed on patients not meeting the guidelines set
by their insurers may not be covered or may be subject to
( aductibles even when a diagnosis of fibrocystic disease is
provided. For Medicare and some other insurers, any code
other than a V code is incompatible with a diagnostic study,
resulting in a claim rejection.
For this reason, it is advisable to list fibrocystic disease as the
chief complaint only when the patient has a current problem.
In these cases, a diagnostic mammography is an appropriate
study. It is strongly recommended in such cases that the
actual problem (e.g., pain or lump) be listed as the chief
complaint to avoid coding problems which can result in
claims denial. For those women with a history of
fibrocystic disease and no current symptoms, a screening
study with a chief complaint of screening mammogram
(V76.12) is the more appropriate way to order
mammography.
Medicare now allows the radiologist to perform additional
studies at the time of a patient's visit. Physicians may order a
mammogram with ultrasound if indicated. For managed care
patients, such an order can minimize the inconvenience to the
patient and the primary care office of securing additional
referrals to cover the ultrasound. Be assured that Breast
- '-iealth Services will only perform the ultrasound if warranted
\~._,JY the mammographic and/or clinical findings AND approved
by the referring physician.
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For your convenience, Breast Health Services has prepared
prescription blanks to facilitate effective ordering of
mammograms. Prescription pads have been made available
to most physicians who routinely order mammograms. If your
office has not received a supply or if you need prescription
pads, please call Breast Health Services at 402-0690.

Wound Care Center@ at Muhlenberg
Hospital Center Offers Monofilament to
Physicians
Virtually every primary care physician treats patients with
diabetes. It is very likely that at least half of these patients
have or will develop diabetic neuropathy. This most common
complication of diabetes results in the loss of protective
sensation which signals pain and helps patients avoid injuries.
As a result:
=> 15% of all people with diabetes will develop foot or leg
ulcers.
=> Patients with diabetes have a 15 fold increase in the risk
of amputation.
=> 42% of those amputated will require contralateral limb
amputation in one to three years, and 56% in three to five
years.
Yet, studies show that a foot inspection is rarely part of the
office visit - as little as 12% of the time.
The American Diabetes Association estimates that diabetic
related amputation could be reduced by 50% if patients were
routinely tested for neuropathy, educated to prevent injury or
complications, and fitted with appropriate footwear as needed.
The Centers for Disease Control has issued a challenge to
reduce the incidence of diabetes related amputation by 40%
by the year 2000. At the Wound Care Center, everything is
being done to reach that goal. The medical team uses the
monofilament to test patients with diabetes during every visit
to the Center. You are invited to do the same. Together, we
can really make a difference.
If you missed receiving a monofilament at our recent Open
House, please contact Peg Cowden, Program Director, at
882-2989 to receive your free monofilament.
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Lehigh Valley Balance and
Vestibular Program

For more information or if you have any questions regarding
this new program, please contact Michael Mueller, PhD,
Administrator of Rehabilitation Services, at 861-2247.
(

Beginning at the end of January, rehabilitation services of the
Lehigh Valley Health Network began providing a new program
for fall prevention, balance retraining, and vestibular
rehabilitation.

The Center for Health Promotion
and Disease Prevention Relocates

This new program -- the Lehigh Valley Balance and
Vestibular Program - will focus on the evaluation of the
patient's functional abilities and assessment of positions or
movements that provoke the patient's symptoms.
Initially, the Balance Master machine will be used as an
integral part of the assessment of the patient. This state-ofthe-art system simulates six sensory conditions providing
precise measurements of the body's performance. By
measuring how much the body sways under different
conditions, these tests can help to determine the nature of the
balance disorder. Based on these findings, an appropriate
therapy program is designed to minimize those symptoms,
improve the patient's balance, teach compensatory strategies,
and increase functional status to promote the return to normal
activities.
The Lehigh Valley Balance and Vestibular Program is
designed to treat individuals who are suffering from any of the
following symptoms:
• Vertigo
• Dizziness
• Balance Problems
• Frequent Falls
• Fear of Falling
• Light-headedness
This outpatient service will initially be provided at Muhlenberg
Rehabilitation Center located at 2545 Schoenersville Road,
Bethlehem, through physician referral only. Patients will be
treated by physical therapists, with consultation services
available from Occupational Therapy, Nutrition, and
Pharmacy.
It is the vision of rehabilitation services to provide a wellness
program through a community outreach program which will
provide fall risk assessments to residents of skilled nursing
facilities, personal care facilities, and at health fairs. In
addition, rehabilitation services envisions a partnership with
the Lehigh Valley community of physicians to provide team
management of the balance disorders in the region through a
complete balance center.

On January 28, the Helwig Diabetes Center and the LOVAR
(Lowering of Vascular Atherosclerotic Risk) Research Office
relocated to the fourth floor of Lehigh Valley Hospital, 17th &
Chew. In addition, Gregory Salem, Operations and Marketing
Manager for the Center for Health Promotion and Disease
Prevention (HPDP) will be located here. Other members of
the HPDP staff have moved to the new Health Center at
Trexlertown, one of many community sites for service delivery.
New telephone numbers include:
Helwig Diabetes Center- (610) 402-4082
LOVAR Research Office- (610) 402-4088
Gregory Salem - (61 0) 402-4085
The fax number for these offices is (61 0) 402-4078.
Hours of operation for the Helwig Diabetes Center and LOVAR,
are 8 a.m. to 5:30 p.m., Monday through Friday. Courtesy (
valet parking is available for patients weekdays from 6 a.m. to
4:30 p.m. Parking is also available in the Visitor's Lot on the
southwest comer of 17th & Chew and in the Fairgrounds
Parking Lot. Entrances to both lots are on Chew Street.

New Preprinted Orders for Gl Hemorrhage Patients
Beginning December 8, 1998, Gl Hemorrhage packets
have been available in the high and moderate acuity
area of the Emergency Department at Cedar Crest &
1-78. The packets contain preprinted orders designed
to be used when the patient with a possible Gl
hemorrhage is going to be admitted as an inpatient.
These orders were developed by a multidisciplinary
team chaired by Carl F. D'Angelo, MD, Chief, Division
of Gastroenterology. The packet also contains
admission progress record, procedure
requesUconsent form, consent for transfusion of
blood and/or blood products, clinical pathway, and
the CareMap®. The packets are located in the file
drawer that contains other preprinted orders and
clinical pathways in each of the two areas mentioned ~ .
earlier. The Emergency Department staff will be able
to assist admitting physicians to locate these packets.
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· Art Show & Auction
Personal Protective Equipment Reminder

(

Che Professional Nurse Council of Lehigh Valley Hospital
and Health Network is joining forces with the Heisman
Fine Arts Gallery, Inc., for "An Evening of Artful
Elegance." This fund-raising art auction will be held on
Friday, March 26, at Lehigh Valley Hospital and Health
Network's new Health Center of Trexlertown.
A preview of 200 custom-framed paintings, watercolors,
serigraphs, lithographs, and etchings will start at 6:30
p.m. The auction will begin at 7:30 p.m.
Special highlights will include a "Collectors' Club Corner"
featuring nationally and internationally known artists.
Cost of admission is $15.00 per person which includes
refreshments and musical entertainment.
All proceeds from the event will benefit the "Friends of
Nursing Program," a philanthropic foundation established
to promote excellence in nursing practice, education, and
research.
For ticket or additional information, please contact the
Professional Development Office at 402-1704.

PLEASE HELP!
Many physicians and other clinical staff are not
using the card access doors to enter the
Emergency Department from the Emergency
Department waiting room. They are simply
walking through the patient triage/registration
area, many without obvious IDs. This
"shortcut" compromises patient confidentiality
and interrupts the triage nurse from his/her
patient evaluation.
PLEASE, when entering the Emergency
Department, use the card access doors and
efrain from using the triage/registration rooms
s the access point. Thank you.

Federal, state, and JCAHO regulations require
that personal protective equipment (i.e.,
protective shoe coverings/blue booties) be
removed before leaving the area of their intended
use (operating room, cath lab, etc.). Failure to do
so may result in the organization, as well as the
individual(s), receiving costly citations for this
unsanitary practice.

Congratulations!
Kevin E. Glancy, MD, Division of Trauma-Surgical
Critical Care/General Surgery, was recently recertified as
a diplomate of the American Board of Emergency
Medicine.
Daniel D. Goldfarb, MD, Department of Psychiatry,
recently passed a stringent examination in Clinical
Psychopharmacology and has been certified as qualified
in this field by the American Society of Clinical
Psychopharmacology, Inc ..
Randy Jaeger, MD, Division of Orthopedic Surgery, was
recently notified that he has become a Fellow of the
American College of Surgeons.
James G. McHugh, MD, Department of Emergency
Medicine, was recently elected to Fellowship in the
American College of Physicians.
Jennifer E. Trottman, MD, Division of
Hematology/Medical Oncology, has been appointed
Acting Medical Director for the Allentown Office of Lehigh
Valley Hospice. Dr. Trottman will be working with the
Hospice team to provide medical leadership for the team,
provide attending coverage with other physicians for
patients who need attending service on the Hospice
inpatient unit, and develop new initiatives in Hospice
which will enhance the continuity and care management
of Hospice patients.
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Papers, Publications and
Presentations
"Linac Radiosurgery for ,Trigeminal Neuralgia," a paper coauthored by George I. Chovanes, MD, Division of
Neurological Surgery, Section of Neuro Trauma; Clinton H.
Leinweber, DO, Department of Radiation Oncology; and Shih
Min Lo, PhD, Radiation Physicist, was presented by Dr.
Chovanes at the Fifth Annual Linac Radiosurgery meeting held
on December 10 in Lake Buena Vista, Fla. This work
represented the first published results utilizing linac-based
radiosurgery for treating this chror''': disorder. The meeting
was attended by over 300 neuros;,... geons, radiation
oncologists, and physicists from the United States and
Europe.
lndru T. Khubchandani, MD, Division of Colon and Rectal
Surgery, was an invited speaker at the Annual Meeting of the
Association of Colon and Rectal Surgeons of India combined
with the Association of Surgeons of India in Ahmedabad, India,
on January 2. He gave a Guest Oration on the "Surgical
Options in the Management of Inflammatory Bowel Disease."
He also chaired a panel on "Management of Advanced Cancer
of the Rectum."
Dr. Khubchandani then traveled to Hong Kong where he was
invited to participate in a one-day scientific symposium to
inaugurate the Department of Colon and Rectal Surgery at the
University of Hong Kong. His chosen subject for delivery there
was "Colon and Rectal Surgery in Academia."
Vincent R. Lucente, MD, Vice Chairperson, Department of
Obstetrics and Gynecology, was one of the co-authors of an
article, "Site-Sr,:.ecific Fascial Defects in the Diagnosis and
Surgical Management of Enterocele," which was published in
Volume 179, Number 6, Part 1, of the American Journal of
Obstetrics and Gynecology.
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LOVAR (Lowering of Vascular Atherosclerotic Risk)
Study Kick-Off will be held at Medical Grand Rounds
on Tuesday, March 9, beginning at Noon, in the
hospital's Auditorium at ~dar Crest & 1-78.
The program, which will be presented by John E.
Castaldo, MD, Principal Investigator, will include a
comprehensive atherosclerosis outcomes based
research initiative offered by Lehigh Valley Hospital's
Center for Health Promotion and Disease Prevention.

Upcoming Seminars, Conferences
and Meetings
Emergency Medicine Grand Rounds
Emergency Medicine Grand Rounds will be held on Thursday,
February 4, beginning at 9 a.m., in Classroom 1 at Lehigh
Valley Hospital, Cedar Crest &1-78.
Topics will include:
0 Pediatric EKG- William F. Bond, MD, Department of
(
Emergency Medicine
0 Tricyclic Overdose, etc.- Perry Fooskas, MD, Department
of Emergency Medicine
0 Diabetic Emergencies- Larry N. Merkle, MD, Chief,
Division of Endocrinology/Metabolism
For more information, please contact Judy Szep in the
Department of Emergency Medicine at 402-7168.

Medical Grand Rounds
Medical Grand Rounds are held every Tuesday beginning at
noon in the hospital's Auditorium at Cedar Crest & 1-78.

For Your Calendar
There will be a general membership meeting of
the Greater Lehigh Valley Independent Practice
Association, Inc., on Tuesday, March 23, at 6
p.m., in the hospital's Auditorium at Cedar Crest
& 1-78.
Physicians attending this meeting will receive
credit toward the Incentive Plan.

Topics to be discussed in February include:
0 February 2 - New Disease Modifying Agents in
Rheumaioid Arthritis
0 February 9 - The Survivorship Movement: Defining the
Medical, Social & Political Parameters of Quality Cancer
Care
0 February 16 - Evidence Based Medicine
0 February 23 - Insults to the Vessel Wall: Redefining
Therapy for Cardiovascular Disease
(.
For more information, please contact Evalene Patten in the
Department of Medicine at 402-1649.

Medical Staff Progress Noms

Who's New
(
Medical Staff
Appointments
Janice H. Axelrod, MD
(Solo)
636 Benner Road
Allentown, PA 18104
(610) 398-8858
Department of Obstetrics and Gynecology
Division of Gynecology
Section of Gynecologic Oncology
Provisional Affiliate
Site of Privileges - LVH & MHC

(

Wanda J. Janik, DMD
(Marsha A. Gordon, DDS)
1050 S. Cedar Crest Blvd.
Suite 104
Allentown, PA 18103-5454
(61 0) 433-5111
Fax: (610) 433-4393
1epartment of Dentistry
uivision of Pediatric Dentistry
Provisional Active
Site of Privileges - LVH &MHC
Maria Lynn Jones, MD
(Robert M. Taxin, DO)
7619 Tilghman Street
Box487
Fogelsville, PA 18051-0487
(610) 395-1936
Fax: (610) 395-7263
Department of Medicine
Division of Generallntemal Medicine
Provisional Active
Site of Privileges- LVH & MHC
Zafar M. Magsi, MD
Northern Valley Primary Care
2014 Laubach Avenue
Northampton, PA 18067-1770
(610) 261-0999
Fax: (610) 261-2187
Department of Medicine
>ivision of Generallntemal Medicine

Provisional Active
Site of Privileges - LVH & MHC
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Change of Status
Tamar D. Earnest, MD
Department of Surgery
Division of General Surg~ry/Trauma-Surgical Critical Care
From: Active/LOA
To: Affiliate
Kenneth M. McDonald, MD
Department of Surgery
Division of Vascular Surgery
From: Active/LOA
To: Honorary
Leo W. Todd, Jr., DO
Department of Family Practice
From: Provisional Active
To: Affiliate

Change of Address
Trexlertown Medical Center
David G. Glueck, MD
J. Stephen Long, MD
Sophia J. Michailidis, DO
Stephen J. Motsay, MD
Brian D. Wilson, MD
6900 Hamilton Blvd.
P.O. Box 127
Trexlertown, PA 18087-0127
(610) 402-0101
Fax: (610) 402-0102
Eric D. Becker, MD
1685 Valley Center Parkway
Bethlehem, PA 18017
(610) 882-2050
Fax: (610) 882-3633
Sarah J. Femsler, MD
(No longer in practice with LVPG)
501 N. 17th Street
Suite 212
Allentown, PA 18104-5687
(61 0) 776-0900
Abel A. Gonzalez, MD
1685 Valley Center Parkway
Bethlehem, PA 18017

(610) 882-2050
Fax: (610) 882-3633
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Nora A. Suggs, MD
322 S. 17th Street
Allentown, PA 18104-6708
(610) 439-4108
Fax: (61 0) 435-4821

Practice/Address Change
Robert B. Kevitch, MD
(No longer in practice with Plastic Surgeons Professional
Group)
(New practice- John A. Altobelli, MD, FACS, PC)
1600 Lehigh Parkway East
Allentown, PA 18103-3093
(610) 437-2378
Fax: (61 0) 820-9983
Michael C. Sinclair, MD
(No longer in practice with Panebianco-Yip Heart Surgeons)
(New practice- Yeisley &Sinclair Cardiothoracic Surgery,
LLC)
1240 S. Cedar Crest Blvd.
Suite 305
Allentown, PA 18103-6218
(610)437-1430
Fax: (610) 437-1782

Two-Year Leave of Absence
Karen M. Matz, MD
(College Heights OBGYN Associates, PC)
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
From: Active
To: Active/LOA
(1/1/99 to 12/31/2000)
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Michael J. Lambo, MD
(Allentown Radiation Oncology Associates)
Department of Radiation Oncology

(

Gene W. Miller, DO
(08-GYN Care, Inc.)
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
Chandrakant C. Shah, MD
(Mertztown Community Medical Center)
Department of Medicine
Division of General Internal Medicine
John S. Stevens, Jr., DO
(08-GYN Care, Inc.)
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
Steven J. Wassner, MD
(Milton S. Hershey Medical Center)
Department of Pediatrics
Division of Nephrology

Deaths
Edgardo S. Cruz, MD
(Allentown Anesthesia Associates, Inc.)
Department of Anesthesiology
11/6/98

(

Robert E. Lentz, MD
Department of Family Practice
Honorary
10/19/98

Allied Health Professionals
Resignations
Appointments
Attila G. Devenyi, MD
(Milton S. Hershey Medical Center)
Department of Pediatrics
Division of General Pediatrics
Douglas G. Field, MD
(Milton S. Hershey Medical Center)
Department of Pediatrics
Division of Gastroenterology
Peter H. Goldman, MD
(Peter H. Goldman, MD- Family Practice)
Department of Family Practice

Christopher T. Bishop, CST
Physician Extender
Technical- Surgical Technician
(Valley Sports & Arthritis Surgeons - Neal A. Stansbury, MD)
Carol E. Bouchard, CST
Physician Extender
Technical- Surgical Technician
(Lehigh Valley Ophthalmic Associates- Alan D. Listhaus, MD(
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Molly J. Breslin, GRNA
. Physician l;xtender
(. 'rofessional - GRNA
(Allentown Anesthesia Associates, Inc. -Alphonse A. Maffeo
MD)

Additional Supervising Physician

I

Michael T. Butler, PA·C
Physician Extender
Physician Assistant - PA-C
(Yeisley & Sinclair Cardiothoracic Surgery, LLC- Geary L.
Yeisley, MD)

Neil B. Laudenslager, PA
Physician Extender
(Orthopaedic Associates of Allentown -James C. Weis, MD)
From: Physician Assistant
To: Surgical Technician

Kenneth P. Rachwal, PA·C
Physician Extender
Physician Assistant - PA-C
(Coordinated Health Systems - Carl B. Weiss, Jr., MD)

Resignations
Charles P. Farley, CRNA
Physician Extender
Professional - CRNA
(Allentown Anesthesia Associates Inc.)

John F. Schell, CRNA
Physician Extender
Professional - CRNA
. 'Allentown Anesthesia Associates Inc. -Alphonse A. Maffeo

.v1D)

'

Change of Supervising Physician
Sherri S. Delgado, CRNP
Physician Extender
Professional- CRNP
From: John J. Cassel, MD
To: Michael D. Pasquale, MD- LVPG-Trauma Surgery
Catherine E. Donati, CRNP
Physician Extender
Professional - CRNP
From: Gregory R. Harper, MD - Oncology Specialists of
Lehigh Valley
To: Clifford H. Lyons, MD- Hamburg Family Practice Center
Patricia L. Donley, RN
Physician Extender
Professional - RN
(ABC Family Pediatricians)
From: Pasquale J. Fugazzotto, MD
To: Scott M. Brenner, MD

(

Edwin M. Straub
Physician Extender
Technical- Surgical Technician
(Orthopaedic Associates of Allentown- Peter A. Keblish Jr.
MD)
' '
Additional Supervising Physician - Neal A. Stansbury, MD Valley Sports & Arthritis Surgeons

Change of Status

Amber J. Herring
Physician Extender
Technical - Dental Assistant
(Marsha A. Gordon, DDS- Marsha A. Gordon, DDS)

(

Page 11

Dennis C. Frederick, PA·C
Physician Extender
Physician Assistant- PA-C
(Orthopaedic Associates of Allentown)
Deborah Logan, CNM
Physician Extender
Professional - Certified Nurse Midwife
(M. Bruce Viechnicki, MD &Associates, PC)
Todd B. Manley
Physician Extender
Technical- Anesthesia Tech Assistant
(Allentown Anesthesia Associates Inc.)
James J. Prudente, CRNA
Physician Extender
Professionai-CRNA
(Allentown Anesthesia Associates Inc.)
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THERAPEUTICS AT A GLANCE
The following actions were taken at the December, 1998 Therapeutics Committee Meeting- Rebecca Hockman, Pharm.D.,
BCPS, Christopher Moore, R.Ph., Joseph Ottinger, R.Ph., MS, MBA

DACLIZUMAB COMES
TO L VH FORMULARY

(

Daclizumab (Zenapax® by Roche
Pharmaceuticals) is a humanized IgG1
monoclonal antibody indicated for use with
cyclosporine and corticosteroids to
prophylax against acute organ rejection in
renal transplant recipients. Daclizumab
acts as an interleukin-2 (IL-2) receptor
antagonist by binding to the Tac subunit(~
chain) of the high affinity IL-2 receptor.
This receptor is found on the majority of
activated T cells and is necessary to
maintain the T cell activation. Daclizumab
offers a different therapeutic option for
induction therapy in renal transplantation,
replacing the use of Orthoclone OKT3®
(OKT3, Muromonab-CD3) in some
patients.
OKT3, a murine monoclonal antibody,
inhibits CD3 on human T cells, which is
- partly responsible for antigen recognition
in T cells. OKT3 successfully inhibits the
majority of T cell functions. OKT3 is
used as prophylaxis against acute organ
rejection in renal transplant recipients, and
is used in the treatment of organ rejection.
Important downfalls with OKT3 include
the following: 1) the production of
antibodies following drug administration
and 2) the potential for the adverse effects
of cytokine release syndrome (CRS).
LVH COST
Drug
Daclizumab
OKT3®
OKT3®

LVH Cost/ Unit
$347.11/ 25 mg
$600.001 5 mg
$240.001 2 mg

Antibody production to OKT3 may result
in decreased efficacy if OKT3 is used in
subsequentrejection episodes. The CRS
may include adverse effects ranging from
fever and chills to life threatening events
such as pulmonary edema, cardiovascular
collapse, seizures, and coma.
Daclizumab offers two therapeutic
advantages compared to OKT3. First, it is
a different agent to use to prevent acute
rejection at renal transplantation, and may
allow OKT3 use to be preserved for the
treatment of acute rejection. Secondly,
there are no reports of CRS to date.
Disadvantages include its lack of utility in
the treatment of acute rejection, the lack of
comparative data with OKT3, and cost
(see below).
Criteria for patient selection for
daclizumab use have been discussed by the
Renal Transplant Review Board, and
approved by the Therapeutics Committee
with the formulary addition of the agent.
The LVH renal transplant patients in
whom daclizumab will be used include the
following:
1)
Patients undergoing a repeat renal
transplant, having previously
received OKT3
2)
Patients at high risk for CRS (i.e.
elderly, cardiovascular dysfunction,
diabetes, and CNS abnormalitie~)

LVH Cost/ 75 kg
$1041.33
$600.00
$240.00

L VH Cost/ Course of Therapy
$5206.65/ 5 doses
$6000.001 10 doses

$2400.00/ 10 doses
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RELAX AND CONSIDER
THE ALTERNATIVES TIZANIDINE
Tizanidine (Zanaflex), a clonidine
derivative, is a centrally acting skeletal
muscle relaxant with alpha2-adrenergic
activity. It increases presynaptic inhibition
and decreases alpha motorneuron
excitability. Its main action is at an
unidentified supraspinal site where it
depresses activity of descending
coeruleospinal effects in the brain stem
and impairs release of excitatory amino
acids from spinal intemeurons.
Tizanidine is indicated for the acute and
. intermittent management of increased
muscle tone associated with spasticity.
The reduction in muscle tone that occurs
with tizanidine has its peak effect 1 to 2
hours after dosing and the effect dissipates
between 3 to 6 hours. Use should be
individualized to correspond to activities
and times when relief of spasticity is most
important and titrated to avoid intolerance.
It has primarily been evaluated in
.
spasticity associated with multiple sclerosis
and spinal cord injury. Tizanidine may
also be effective in the treatment of
spasticity associated with chronic
myelopathy, syringomyelia and
hemiplegia; muscle spasm associated with
acute low-back pain; stiff-man syndrome;
neuropathic pain states; chronic tensiontype headaches; and may play a role in the
management of morphine and heroin
dependence.
Following oral administration tizanidine is
completely absorbed; however, oral
bioavailability is only approximately 40%
due to extensive frrst-pass metabolism.
Food increases the peak concentration by
approximately one-third and shortens the
time to peak by approximately 40 minutes;

however, the extent of absorption is not
affected. Plasma protein binding is low
(30%). The elimination half-life of
tizanidine is approximately 2.5 hours.
Approximately 95% of the administered
dose is metabolized. Urinary excretion of
unchanged drug within 24 to 72 hours is
0. 4% to 2. 7 % of the administered dose.
The most common adverse reactions
include drowsiness and dry ·mouth. Other
reactions include dizziness, fatigue,
flushing, depression, urinary incontinence,
urine retention, dysarthria, muscle
weakness, sleep disorders, bradycardia,
hypotension and gastrointestinal
disturbances. Tolerance to the sedation or
other adverse effects does not appear to
occur. Sedation is sometimes severe and
can interfere with daily activities. It
appears to be dose related. Dose-related
retinal degeneration and corneal opacities
were observed in animal studies with
tizanidine. Such effects have not been
observed in clinical trials. In clinical
trials, approximately 5 % of patients treated
had elevations of liver function tests to
areater
than 3 times the upper limit of
e>
normal. Monitoring of aminotransferase
levels is recommended during the first 6
months of therapy and periodically
thereafter.
Hypotension may occur when tizanidine is
used in combination with antihypertensive
medications. Alcohol increased the AUC
of tizanidine by approximately 20% and
increased its peak concentration by
approximately 15%. This was associated
with an increase in side effects with
tizanidine. In addition, the CNS
depressant effects of alcohol and tizanidine
are additive. Sedation is also likely to be
additive when tizanidine is used in
combination with other CNS depressants.
Clearance of tizanidine was reduced 50%

(

(
·

(

l
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in women taking oral contraceptives.
Tizanidine should be used with caution in
this population and initial tizanidine doses
should be reduced.

therapeutic substitution.

Effects are dose related; therefore, treatment
should begin with a single oral dose of 4mg
and the dose should be increased in 2 to 4mg
increments as needed. The dose can be
repeated at 6 to 8-hour intervals, although
the manufacturer recommends a maximum of
three doses in 24 hours. The total daily dose
should not exceed 36mg. Lower initial doses
are recommended in patients with renal
insufficiency and in women on oral
contraceptives. Baclofen (Lioresal) is
currently the only similar agent available. It
is expected that Tizanidine will be utilized in
those patients unable to tolerate baclofen.
The cost of Zanaflax is substantially more
than generic baclofen (AWP $1.05 per 4mg
tablet vs. @ $0.10 for lOmg of baclofen).

In addition to the well known shortages of
albumin and IV immune globulin, several
other products have recently joined this
growing list with no discernible end in sight.

AUGMENTIN® AUTOSUBSTITUTION POLICY
CHANGE
The Therapeutics Committee, December
meeting, approved the discontinuation of
the automatic substitution policy for
Augmentin® 875 mg (amoxicillin 875 mg/
clavulanic acid 125 mg/tab) po Q12H to
Augmentin® 500mg (am.oxicillin 500
mg/clavulanic acid 125 mg/tab) po Q8H.
The daily dose of clavulanic acid is
reduced with the Augmentin® 875 mg
Q12H regimen. The reduction in
clavulanic acid has the potential for
decreased GI side effects. The LVH cost
of each regimen is similar with
Augmentin® 500 mg po Q8H at $7.08/day
and Augmentin® 875 mg po Q12H at
$7.061day. Effective immediately,
medication orders for Augmentin® 875 mg
or Augmentin® 500 mg will be dispensed
as written, without the occurrence of a

(

NATIONAL PRODUCT
SHORTAGES

Schein Labs, the primary manufacturer of
generic metoprolol (Lopressor®) injection,
has discontinued its manufacturing
operations related to this product. This
company had been the largest supplier of all
metoprolol injection in the USA and its
absence has not been offset by any other
vender to date. Novartis, the manufacturer
ofLopressor injection, has not been able to
"ramp-up" production to date, and because
of declining market share, its depot supplies
have not been sufficient _to satisfy demand.
Therefore, periodic shortages ofthis agent
are expected to continue for the next several
months. Alternatives include use of the oral
product, injectable propranolol, or in
selected cases, the use of atenolol injection.
Currently, aletnolol (Tenonnin®) injection
only has indications for a one time dose
followed by immediate conversion to oral
atenolol.
Phenobarbital injection is also not available
for an indeterminate time due to a scarcity
of raw materials. Oral products are not
affected at the current time. A
recommendation for alternative agents
would be contingent on the type of seizures
that are being treated.
Urokinase (Abbokinase) shortages are the
result of an FDA concern related to aspects
of the manufacturing process utilized for
this product. The company (Abbott) has
been unable to release any of the 12lots of
product that were prepared. Abbott and the
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FDA are working closely to resolve this
issue as quickly as possible, but this activity
has been ongoing since November 27, 1998.
A company spokesperson indicated that a
resolution date was "difficult to predict".
An allocation system had been established,
but was quickly overwhelmed. The
Pharmacy has not received any shipments
since early-December and our supplies at
this writing are negligible.

(

The Department of Pharmacy continues to
make every effort to secure all of the above
agents as they become available and is in
constant contact with the various suppliers
involved.

(

pt\1298.hi
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9:25 a.m. Off-Pump Sternotomy and
Minimally Invasive Beating Heart
Coronary Artery Bypass Grafting
10:00 a.m. Panel Discussion on
Minimally Invasive Heart and
Lung Surgery
10:15 a.m. Break and Exhibits
10:30 a.m. Update on Ventricular Assist
Devices and the Artificial Heart
11 :05 a.m. Discussion
11 :10 a.m. Stentless Aortic Valves
11:45 a.m. Discussion
11:50 a.m. Summary and Closing
Remarks
12:00 p.m. Adjournment, Buffet
Luncheon, Exhibits

Announcement:
Health Librazy and Learning Center
(HLLC) at Trexlertown Health Mall will
be opening this month.
HLLC is a state-of-the-art health
information library with health care
professionals on staff ready to help with
any health questions. Patient learning
will be tailored to meet diverse needs and
styles through a multi-media approach.
Information on a variety of health topics
will be available through computer
access, videos, books, brochures,
individualized self-care information
'
classes, support groups, and seminars.

(

Faculty includes:
RobertS. Boova, :MD Chief, Division of
Cardiothoracic Surgery Bryn Mawr
Hospital & Systems Chief, Cardiac
Surgery Jefferson Main Line Hospital
System

For more information about the HLLC or
for a tour, please contact Deb Swavely,
L VHHN Patient Education Specialist at
402-8478 or HLLC at 402-0180.

Symposium Announcement:

G. Michael Deeb, :MD, Professor of
Surgery, Director of Adult Cardiac
Surgery, University of Michigan Health
Systems

Sixth Annual Update on Heart and Lung
Surgery will be held on Saturday, April
10, 1999 in the LVH Cedar Crest
Auditorium.

(

James D. Fonger, :MD, Director of
Cardiac Surgery, Washington Adventist
Hospital

Agenda:
7:30a.m. Registration and Continental
Breakfast
8:00 a.m. Opening Remarks & Special
Presentation
8:15 a.m. Thoracoscopic Minimally
Invasive Lobectomy
8:50a.m. Heartport Minimally Invasive
Coronary Artery Bypass Grafting

Ralph J. Lewis, :MD, Clinical Professor
of Surgery, Chief: Thoracic and
Cardiovascular Surgery, St. Peter's
Medical Center-Robert Wood Johnson
University Hospital University of
Medicine and Dentistry of New Jersey

1
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D. Lynn Morris, MD, Associate
Professor of Clinical Medicine
Penn State University College of
Medicine & Chief, Division of
Cardiology, L VH

New Books- Cedar Crest & I-78.
"The Heart: Physiology, From Cell to
Circulation," 3rd edition.
Author: L. Opie WG 202 061h
(Reviewed in the Dec. 24th issue of "The
New England Journal of Medicine")

Raymond L. Singer, MD, Clinical
Assistant Professor of Surgery
Penn State University College of
Medicine & Associate Chief, Division of
Cardiothoracic Surgery, LVH.

"Improving Patient Satisfaction Now:
How to Earn Patient and Payer Loyalty"
Author: A. Nelson, et al. W 85 134 1997

(

"Principles and Practice of Surgery for
the Colon, Rectum, and Anus," 2nd ed
Author: P. Gordon, WI520 G664p 1999

For more information or to register,
please contact Bonnie Schoeneberger via
Email or phone at (610) 402-1210.

New Books - 17th & Chew.
"Seminars in Perinatology" Topic:
"Endocrine Disorders in Pregnancy"
Guest Editor: P. Gamer Vol. 22, No.6

Continuing Education:
See the following calendar for all grand
rounds and tumor boards.

"Psychiatric Clinics ofNorth America"
Topic: "Diagnostic Dilemmas, Part II"
Guest Editor: David Tomb Vol. 21, No.4

News from the Library:
The Library is accepting 1998 "PDRs"
for redistribution. When you receive
your 1999 "PDR," please keep the
Library in mind. We have a list of
departments that use "PDRs"
infrequently and, therefore, do not need
to purchase a new one.

"Loss During Pregnancy or in the
Newborn Period: Principles of Care with
Clinical Cases and Analyses" Author: J.
Woods, et al. WQ 225 W895d 1997.

News from the Office of
Educational Technology:

OVID/PubMed TRAINING.
To schedule a one-on-one OVID
(MEDLINE) training session, call
Barbara Iobst in the Health Sciences
Library at 402-8408 between 8:30a.m.5:00p.m., Monday-Friday. Barbara can
also instruct you in the use ofPubMed, a
free, Web-based MEDLINE service
offered by the National Library of
Medicine (NLM). MEDLINE can be
searched directly using PubMed.

Internet Workshop:
Internet workshops focusing on how to
use the internet to search and access job
related information will be held in
JDMCC Suite 401 on:
February 9 - 9:30 am- 12 Noon
February 12 - 9:30 am- 12 Noon
February 17 - 1:00 pm- 3:30 pm.
To register E-mail Chris Sarley or phone
at 402-1641.
Any questions, concerns or comments on articles from

CEDS, please contact Sallie Urffer 402-1403
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Medical Std h,gg'US Rates
Grand Round and
Tumor Board Schedule

SUNDAY

Feb.

MONDAY
12 Noon CIR Tumor Board
- JDMCC - CR1 AlB

TUESDAY
1 7 am Surgleal Grand Rounds CC·Aud - Surgical Critical Care

urJ

WEDNESDAY
2

THURSDAY
3

12 Noon Combined Tumor
Board - JDMCC • CR1 AlB

FRIDAY
4 7 am GYN Tumor Board/OBGYN
Grand Rounds -17 Aud

8am Pediatric Grand Rounds •
17-Aud

SATURDAY
5

6

12

ll

19

20

26

27

!

12 Noon Breast Tumor Board·
JDMCC- CR1 AlB

12 Noon Medical Grand Rounds
CC-Aud • New Disease
Modifying Agents In Rheumatoid
ArthrHis
8 7am Ambulatory Clin Guideline
Dev-SON

7

9 12 Noon Pulm Tumor
Board- JDMCC • CR1 AlB

10

12 Noon G.l. Tumor Board
- JDMCC· CR1 AlB

11 7am OBGYN Grand Rounds -17
Aud

7 am Surgical Grand Rounds CC·Aud - CIR Resident

12 Noon Pediatric Noon Conf •
17Aud

8am Pediatric Grand Rounds 17-Aud

12 Noon Breast Tumor Board·
JDMCC·CR1AIB

12 Noon Medical Grand Rounds
CC-Aud

14

12 Noon CIR Tumor Board
• JDMCC • CR1 AlB

IS

7 am Surgical Grand Rounds CC-Aud -Oral Surgery

16

17

12 Noon Combined Tumor
Board· JDMCC • CR1 AlB

18

8am Pediatric Grand Rounds 17-Aud

7am OBGYN Grand Rounds -17
Aud
12 Noon Breast Tumor BoardJDMCC· CR1 AlB

12 Noon Medical Grand Rounds
CC·Aud - Evidence Based
Medicine

21

22

7 am Surgleal Grand Rounds •
CC-Aud - Plastic Surgery

23

24

12 Noon Cancer Comm. JDMCC· CR1 AlB

25

7am OBGYN Grand Rounds -17
Aud

Sam Pediatric Grand Rounds •
17-Aud

12 Noon Pediatric Noon Conf •
17Aud

12 Noon Medical Grand Rounds
CC-Aud -Insults to Vessel Wall:
Redefining Therapy for CV
Disease

12 Noon Breast Tumor BoardJDMCC· CR1 AlB

12 Noon Urology Tumor BoardJDMCC • CR1 AlB

28

Any questions, concerns or comments on articles from CEDS, please contact Sallie Urffer 402-1403
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